Dr. Ludomirski is the founder of the Vitalife Life Sciences Fund. He is an internationally renowned physician with more than 20 years experience in life sciences, with particular expertise in medical devices, health homecare, and biomaterials.
Ms. Charlap joined Vitalife in 2002 and became a venture partner in 2009. Her main responsibilities are investor relations, business development and financial planning for the portfolio companies. Edna serves on the board of directors of DIR Technologies and MST (Medical Surgical Technologies).
More...Mr. Weisman is a Founder and Managing Partner of SCP Vitalife Partners, and a Partner of SCP Partners, with more than $1 billion under management in a series of venture capital investment funds. He has been a member of the investment committee of Vitalife Life Sciences Fund since its inception, and has worked closely with Vitalife since SCP Partners became Vitalife's U.S. sponsor in 2002.
He has extensive experience in venture capital investing, particularly in the life sciences area, dating back to 1990.
Joseph Gaspar was appointed as an Executive Vice President in 2008 and as Chief Financial Officer in 2001. He was appointed as a corporate vice president in 2000 and served as corporate vice president - strategy, technology and subsidiaries from 2000 until 2001.
More...Roni is a veteran entrepreneur having founded several companies in diverse fields. Before joining DIR Technologies, Roni has held several managerial and board member positions, and served as the CFO of SCD, partnership of Elbit Systems and Rafael Ltd., for approximately 20 years .
More...DIR Technologies is committed to excellence and accuracy, aiming to lead in cutting edge technology for pharmaceutical authentication and in situ quality assurance.
DIR Technologies is dedicated to maintain a supportive environment for laboratory staff, physicians, technologists, and technicians.
Products range from the basic manual operation hardware, all the way to fully automatic systems, scanned acquisition and automatic analysis.